Evidence-Based Medicine Guidelines
Infliximab for rheumatoid arthritis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Infliximab for Rheumatoid Arthritis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/453726/all/Infliximab_for_rheumatoid_arthritis.
Infliximab for rheumatoid arthritis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/453726/all/Infliximab_for_rheumatoid_arthritis. Accessed November 24, 2024.
Infliximab for rheumatoid arthritis. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/453726/all/Infliximab_for_rheumatoid_arthritis
Infliximab for Rheumatoid Arthritis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 November 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/453726/all/Infliximab_for_rheumatoid_arthritis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Infliximab for rheumatoid arthritis
ID - 453726
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/453726/all/Infliximab_for_rheumatoid_arthritis
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
